Citation Impact
Citing Papers
Stress and the Individual
1993 Standout
HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol
2005 Standout
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome
2015 StandoutNobel
Gout and hyperuricemia
2002
The biology of human natural killer-cell subsets
2001 Standout
c-Rel Is a Target of Pentoxifylline-Mediated Inhibition of T Lymphocyte Activation
1997
Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantation
1990
Prognostic Factors That Determine the Long-Term Survival of Patients with Unresectable Metastatic Melanoma
2008
Prognostic factors of survival and rapid progression in782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Français d’Immunothérapie
2002
Increase in Total Plasma Homocysteine Concentration After Cardiac Transplantation
1995
Retargeting serum immunoglobulin with bispecific diabodies
1997 StandoutNobel
The tissue inhibitor of metalloproteinases-1 improves migration and adhesion of hematopoietic stem and progenitor cells
2013 StandoutNobel
Tacrolimus-based triple-drug immunosuppression minimizes serum lipid elevations in pediatric cardiac transplant recipients
1999
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Risiko der Nebennierenrindeninsuffizienz nach Herztransplantation
1991
Cancer immunotherapy via dendritic cells
2012 Standout
Definitions of Cytomegalovirus Infection and Disease in Transplant Recipients
2002 Standout
Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients
1988
Photopolymerizable hydrogels for tissue engineering applications
2002 Standout
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Interferon in the treatment of hairy-cell leukemia
2003
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy
2010 StandoutNobel
Regulation of tumour immunity by CD25+ T cells
2002 StandoutNobel
Inhibition of nuclear factor-κB activation by pyrrolidine dithiocarbamate prevents chronic FK506 nephropathy
2003 StandoutNobel
Serum lipid abnormalities in heart transplant recipients: predominance of HDL2-like particles in the HDL pattern
1990
Graft-versus-host disease
2009 Standout
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Treatment of hairy-cell leukemia
1990
CYTOKINE CASCADES IN ACUTE GRAFT-VERSUS-HOST DISEASE1
1997
Hematopoietic Stem-Cell Transplantation
2006 Standout
Differentiation of cytotoxicity using target cells labelled with europium and samarium by electroporation
1994
Chronic renal transplant loss
1995
ACUTE MYELOID LEUKAEMIA IN THE ELDERLY: BIOLOGY AND TREATMENT
1993
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
1997 Standout
Everolimus for the Prevention of Allograft Rejection and Vasculopathy in Cardiac-Transplant Recipients
2003 Standout
Effect of Pravastatin on Outcomes after Cardiac Transplantation
1995 Standout
Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout
2005 Standout
Prospective evaluation of peripheral vascular disease in heart transplant recipients
1995
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
2007 Standout
A review of autologous hematopoietic cell transplantation
2000 Nobel
Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease
1991
Renal cell carcinoma
2017 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996
2000 Standout
Underrepresentation of Patients 65 Years of Age or Older in Cancer-Treatment Trials
1999 Standout
Two's company, three's a crowd: can H 2 S be the third endogenous gaseous transmitter?
2002 Standout
Bone Marrow Transplantation
1993
IL-7 Stimulates T Cell Renewal Without Increasing Viral Replication in Simian Immunodeficiency Virus-Infected Macaques
2003 StandoutNobel
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
The pathobiology of chronic rejection
1989
Immunosuppressive Agents and Endothelial Repair
1995
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Participation of Patients 65 Years of Age or Older in Cancer Clinical Trials
2003 Standout
Role of Cytokine Therapy in 2006 and Beyond for Metastatic Renal Cell Cancer
2006
CD8+minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells
1999
Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine
2001 StandoutNobel
Photopolymerization of composite resin using the argon laser.
1999
Roles of Infectious Agents in Atherosclerosis and Restenosis
1997 Standout
Cyclosporine a inhibits tissue factor expression in monocytes/macrophages
1996
PLEIOTROPIC EFFECTS OF STATINS
2004 Standout
Simvastatin Reduces Graft Vessel Disease and Mortality After Heart Transplantation
1997
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Endoscopic sphincterotomy of the ampulla of Vater
1974 Standout
Interleukin-7: from bench to clinic
2002
The pharmaceutics and delivery of therapeutic polypeptides and proteins
1993
Melanocyte Destruction after Antigen-Specific Immunotherapy of Melanoma
2000
Treatment of hairy cell leukemia with recombinant alpha-interferon
1986
Growth Factors and Cancer
1991 StandoutScience
Cytokine dysregulation and acute graft-versus-host disease
1992
Effectiveness of Choledochoduodenostomy and Transduodenal Sphincterotomy in the Treatment of Benign Obstruction of the Common Duct
1971
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Hypercholesterolaemia and vascular disease after transplantation
1991 StandoutNobel
Stem cell factor modulates avidity of alpha 4 beta 1 and alpha 5 beta 1 integrins expressed on hematopoietic cell lines
1995
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Biology and clinical relevance of human natural killer cells
1990
Task force 5: Complications
1993
Rational approaches to human cancer immunotherapy
2003
Cytomegalovirus Antigen Expression, Endothelial Cell Proliferation, and Intimal Thickening in Rat Cardiac Allografts After Cytomegalovirus Infection
1995
Treatment of hairy cell leukemia with recombinant alpha-interferon
1986
Works of Thompson Ja being referenced
Hyperlipidemia after clinical heart transplantation.
1989
Lipid mediators in organ transplantation: does cyclosporine accelerate coronary atherosclerosis?
1987
Toxicity and immunomodulatory effects of interleukin-2 after autologous bone marrow transplantation for hematologic malignancies
1991
Metastatic renal cell carcinoma: long-term survival after therapy with high-dose continuous-infusion interleukin-2.
1997
Are steroids essential for successful maintenance of immunosuppression in heart transplantation?
1988
Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease.
1991
Patient response to dental laser treatment; a preliminary report.
1991
Pentoxifylline inhibits integrin-mediated adherence of interleukin-2- activated human peripheral blood lymphocytes to human umbilical vein endothelial cells, matrix components, and cultured tumor cells
1994
Induction by interleukin-7 of lymphokine-activated killer activity in lymphocytes from autologous and syngeneic marrow transplant recipients before and after systemic interleukin-2 therapy.
1993
Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
1985
Acute pancreatitis following choledochotomy.
1957
Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
1997
Childhood polyarteritis nodosa presenting as a relapsing movement disorder.
2000
Very low dose alpha-2b interferon for the treatment of hairy cell leukemia [see comments]
1989
Lymphokine-activated killer function following autologous bone marrow transplantation for refractory hematological malignancies.
1989
Very low dose alpha-2b interferon for the treatment of hairy cell leukemia [see comments]
1989
Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia
1996